Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...
News-Medical.Net on MSN
Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...
Microtubules perform an active role in communication within the cell by transmitting received signals to the cell's ...
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...
AZoLifeSciences on MSN
Researchers Develop High-Throughput Technique to Decode T-Cell Receptors
Studying T cells, the immune cells most responsible for responding to infections and cancers, just received a significant boost in the form of a new technique from St. Jude Children's Research ...
By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.
Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.
Cancer is a multifactorial chronic disease, with its pathogenesis and progression influenced by various factors. The immune ...
News-Medical.Net on MSN
Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to ...
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in ...
Cancer's 'Dark Matter' Outshines Neoantigens In Landmark Debate. EINPresswire/ -- UbiVac, a private, clinical-stage immuno-oncology company, debuted new data and Dark Matter emerged victorious in a hi ...
Researchers have found a small but powerful switch inside breast cancer cells that helps them survive stressful conditions.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈